Refine by
Pulmonary Embolism Articles & Analysis
25 news found
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the pulmonary arteries and for ...
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). ...
The frequency of net-clinical benefit events - a composite of stroke or systemic embolism, major bleeding, myocardial infarction, acute coronary syndrome, or cardiovascular death - was 13.8 per 100 patient years in the rivaroxaban and 13.6 in the VKA group (95% CI 0.72 to 1.31, HR=0.97). ...
ByBayer AG
Rivaroxaban Rivaroxaban, as an antithrombotic drug, is widely used in the treatment and prevention of deep vein thrombosis (DVT) symptoms prior to hip or knee replacement surgery, treatment of venous thromboembolism (VTE) and nonvalvular atrial fibrillation, as well as treatment of DVT and pulmonary embolism (PE). Alfa Chemistry offers rivaroxaban for related ...
“While we saw the mass, we weren’t sure it was the cause of the symptoms the patient was experiencing, but given his condition and age, our recommendation was to take out the mass – especially because these types of masses, while small in this case, could break off and cause pulmonary embolism,” Dr. Dutcher explained. Until now, the only ...
(NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive outcomes of the fully enrolled 800-patient FLASH registry in pulmonary embolism (“PE”). The data was presented during a Late-Breaking Clinical Trial ...
PEERLESS commenced earlier this year and compares FlowTriever to catheter-directed thrombolytics in pulmonary embolism. “Anticoagulation is still the predominant therapy used in the management of DVT and in some studies has been associated with post-thrombotic syndrome (PTS) in up to 50% of patients,” said Dr. ...
Xarelto is approved for more venous and arterial thromboembolic (VAT) conditions than any other NOAC: The prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors The treatment of pulmonary embolism (PE) in adults The treatment of deep vein thrombosis (DVT) in ...
ByBayer AG
Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE). The device is designed to avoid well-documented risks of perforation, migration, fracture, and thrombosis currently associated with IVC filters. ...
The LOBO occluders integrate patented HDBRAID® technology and an innovative design to provide interventional physicians with a One-and-Done solution for embolization. The highly occlusive braided structure rapidly reduces flow and enables single-device occlusions of blood vessels throughout the body. ...
” “When diagnosing and treating critical pathologies like pulmonary emboli and hemorrhagic strokes, every second counts,” said Dr. ...
ByAidoc
Xarelto is the only Factor Xa anticoagulant FDA approved for pediatric patients and offers a flexible weight-based dosing Xarelto is available in both oral tablet and liquid suspension formulations for use in appropriate children less than 18 years of age Convenient liquid formulation advances standard of care for children; alleviates administration challenges found with injectable ...
ByBayer AG
Along with seven FDA-cleared solutions for intracranial hemorrhage, acute C-spine fractures, intra-abdominal free gas, rib fractures, large vessel occlusions, and pulmonary embolism on both dedicated and non-dedicated (incidental) exams, the Aidoc OS platform integrates AI solutions from Imbio, Riverain, Icometrix, Subtle Medical and ScreenPoint Medical, together ...
ByAidoc
LMWHs are injectable anticoagulant drugs used primarily to treat and prevent deep vein thrombosis and pulmonary embolism. Redesca has more than 8 years of proven in-market safety internationally. and more than 150 million patient days treated in Europe alone. ...
Delivering value to nearly 600 medical centers across the globe, Aidoc’s suite of AI solutions enable radiologists to expedite patient treatment and improve quality of care by flagging acute anomalies such as pulmonary embolism, intracranial hemorrhage, and stroke – in real time. ...
ByAidoc
Apixaban (Eliquis®, Bristol-Myers Squibb/Pfizer) and rivaroxaban (Xarelto®, Janssen/Bayer) are two of the most commonly prescribed anticoagulants worldwide, including more than 5 million patients1 annually in the United States who are chronically on these medications to reduce the risk of deadly blood clots due to atrial fibrillation, prior history of heart attack or stroke, deep vein ...
Aidoc’s solutions enable radiologists to expedite patient treatment and improve quality of care by immediately flagging acute anomalies such as pulmonary embolism, intracranial hemorrhage, and stroke – in real time. ...
ByAidoc
Published in this month’s Experimental Physiology, the study, entitled, “Temporal changes in pulmonary gas exchange efficiency when breath-hold diving below residual volume,” demonstrated that breath-hold diving to depths associated with major lung compression, or “lung squeeze,” caused acute impairments in pulmonary gas exchange. ...
Aidoc, the leading provider of enterprise AI solutions, announced today the launch of an industry first: an AI-based automated activation solution that facilitates rapid risk assessment and care coordination for high-risk pulmonary embolism (PE) patients. Aidoc’s PE Care Coordination includes Aidoc’s FDA-cleared solution for triage and notification ...
ByAidoc
A recent clinical study published by medical researchers from UC San Diego School of Medicine has established that an expired breath sampling method is comparable to the long-established blood-based method (ABG) of measuring pulmonary gas exchange efficiency. Published in the American Journal of Physiology Lung Cellular and Molecular Physiology, the study, entitled ...